Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Deciphera Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | $0 | $10.58 | Jun 11, 2024 | Direct |
Candel Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14.2K | Jun 26, 2024 | Direct | ||
Renovacor, Inc. | Director | Common Stock | 0 | $8.00 | Dec 1, 2022 | Direct | |
Renovacor, Inc. | Director | Stock Option | 0 | Dec 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CADL | Candel Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
NA | Deciphera Pharmaceuticals, Inc. | Jun 11, 2024 | 5 | $0 | 4 | Jun 11, 2024 | Director |
CADL | Candel Therapeutics, Inc. | Jun 28, 2023 | 1 | $0 | 4 | Jun 29, 2023 | Director |
DCPH | Deciphera Pharmaceuticals, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
RCOR | Renovacor, Inc. | Dec 1, 2022 | 5 | $0 | 4 | Dec 5, 2022 | Director |
CADL | Candel Therapeutics, Inc. | Oct 13, 2022 | 1 | $0 | 4 | Oct 17, 2022 | Director |
DCPH | Deciphera Pharmaceuticals, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
RCOR | Renovacor, Inc. | May 25, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
RCOR | Renovacor, Inc. | Sep 3, 2021 | 1 | $0 | 4 | Sep 8, 2021 | Director |
RCOR | Renovacor, Inc. | Sep 2, 2021 | 0 | $0 | 3 | Sep 8, 2021 | Director |
CADL | Candel Therapeutics, Inc. | Jul 26, 2021 | 0 | $0 | 3 | Jul 26, 2021 | Director |
DCPH | Deciphera Pharmaceuticals, Inc. | Jun 23, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |